ODDO BHF Asset Management’s Astria Therapeutics ATXS Stock Holding History

ODDO BHF Asset Management’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-317,300	Closed	-$4.15M	–	278
2025 Q4	$4.15M	Buy	+317,300	New	+$3.79M	0.16%	126

ODDO BHF Asset Management's ATXS Position: Q1 2026 in Review

ODDO BHF Asset Management sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 317,300 shares — an estimated $4.15M sold.

ODDO BHF Asset Management first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $4.15M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

ODDO BHF Asset Management reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
ODDO BHF Asset Management sold 317,300 Astria Therapeutics shares in Q1 2026, an estimated $4.15M.
ODDO BHF Asset Management first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
ODDO BHF Asset Management's Astria Therapeutics position peaked at $4.15M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on ODDO BHF Asset Management's 13F filing for Q1 2026, filed 18 May 2026.